Mirna Therapeutics Inc., after raising tens of millions of dollars in venture capital and research grants and going public, has reached the end of the road.
The Austin-based biotech company halted drug development last year following deaths of patients in clinical trials— now it is being acquired by a Boston-area suitor in a reverse merger.
Synlogic Inc. of Cambridge, Massachusetts, which focuses on drugs that affect bacteria in the gut, announced Tuesday its merger with Mirna (Nasdaq: MIRN),…
#URLinkedUp Austin Business News – Local Austin News | Austin Business Journal http://www.bizjournals.com/austin/news/2017/05/16/austin-cancer-fightingbiotech-mirna-therapeutics.html?ana=RSS%26s=article_search
#Austin Check out URLinkedUp > http://www.urlinkedup.com